{"id":11310,"date":"2025-07-27T01:30:32","date_gmt":"2025-07-26T23:30:32","guid":{"rendered":"https:\/\/valintermed.com\/?p=11310"},"modified":"2025-07-27T01:30:32","modified_gmt":"2025-07-26T23:30:32","slug":"bolezn-goshe-2-tipa","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/sick-goshe-type-2\/","title":{"rendered":"Gaucher disease type 2"},"content":{"rendered":"
<\/div>\n

Gaucher disease type 2 (BG2) is a rare inherited disorder belonging to a group of lysosomal storage diseases caused by a deficiency of the enzyme glucocerebrosidase. Unlike the more common form of Gaucher disease (type 1), which primarily manifests as hematosarcoma and systemic disorders, Gaucher disease type 2 is characterized by a neuropathic form, occurring mainly in infants and young children. LB2 is a severe disease that progresses from early childhood and leads to significant neurological impairment, including developmental delay, seizures, and death, often within the first two years of life. <\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n